Hyderabad: Pharma major Dr Reddy's Laboratories has launched Quetiapine fumarate tablets in the US market.
A bioequivalent generic version of Seroquel tablets, it is indicated for the treatment of schizophrenia and other depression-related disorders.
The Hyderabad-based company has launched the drug in the US market from March 27, according to a release issued here on Wednesday.
The Seroquel brand had US sales of approximately $4.6 billion for the most recent 12 months ending December 2011, according to IMS Health, the release said.
The launch of Quetiapine was part of Dr Reddy's strategy to focus on limited competition products in the US market.
According to the information shared by the company in the after the announcement of third quarter results, it had lined up a ‘good' number of launches in the US market which is expected to drive revenue growth in the next financial year.
Dr Reddy's stock climbed 1.11 per cent on Bombay Stock Exchange on Wednesday to end at Rs 1,698.65.
No comments:
Post a Comment